In the present study, we addressed the clinical and prognostic significance of PAICS in CRC using multiple cohorts based on different platforms, leading to the identification of decreased PAICS expression and loss of PAICS protein as novel prognostic biomarkers for poor survival outcome, especially in patients with stage III CRC. Here, PAICS is linked to colorectal carcinoma.